India, April 24 -- Acting Attorney General Todd Blanche recently shared that the Justice Department is moving to change the classification of some types of marijuana under federal law, which marks a notable shift in how the U.S. views drug policy.
According to Blanche, cannabis that is FDA-approved and state-licensed will be reclassified from Schedule I to Schedule III under the Justice Department's guidelines.
Schedule I substances, like heroin and LSD, are seen as extremely dangerous and have no accepted medical use, whereas Schedule III drugs are recognized as having a moderate to lower potential for dependency.
The Justice Department is also planning to hold a quick hearing on June 29 to look into broader changes regarding marijuana'...